Navigation Links
SuperScript II RNase H- Reverse Transcriptase from Invitrogen

ProductsSuperScript II RNase H- Reverse Transcriptase from Invitrogen
Company Invitrogen
Item SuperScript II RNase H- Reverse Transcriptase
Price 
Description SuperScript™ II RNase H- Reverse Transcriptase (RT) is an improved version of the SuperScript™ RNase H- RT. It is a DNA polymerase that synthesizes a complementary DNA strand from single-stranded RNA DNA or an RNA:DNA hybrid. This enzyme is genetically engineered by the introduction of point mutations rather than a deletion in the RNase H active center. Like SuperScript™ RT SuperScript™ II RT has 106- to 107-fold reduced RNase H activity. Unlike SuperScript™ RT however the selective mutations within the RNase H domain maintain full polymerase activity. This structural modification eliminates degradation of RNA molecules during first-strand cDNA synthesis and gives SuperScript™ II RT superior performance characteristics.
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
2. SuperScript III RNase H- Reverse Transcriptase from Invitrogen
3. SuperScript Plasmid System and MAX Efficiency DH10BCompetent Cells from Invitrogen
4. SuperScript Indirect cDNA Labeling System from Invitrogen
5. GeneRacer Kit with SuperScript II RT and Zero Blunt TOPO PCR Cloning kit for Sequencing from Invitrogen
6. DNase I (RNase-free) (2 U/l) from Ambion
7. QIAGEN RNase Inhibitor (7500 U) from QIAGEN
8. ShortCut RNase III from New England Biolabs
9. RNase H from Roche Applied Science
10. RNase-Free Dnase from BD Biosciences Pharmingen
11. RQ1 RNase-Free DNase from Promega
...53; Agarose Gel-Digesting Preparation contains a u... EPICENTRE for simple, quantitative recovery of in...ose gels following electrophoresis in TAE, TBE, MO...directly in the TAE, TBE, MOPS, and phosphate elec...
...heer in-house demand is causing shortages in your ...s antibody. This can cause unwanted distractions, ...for your hard work and endeavour! Bring us your id...nally. We work under ISO 9001 quality assurance in...
...assays for interferons are cytopathic effect inhib...ys. Sample types include; tissue culture supernat...ons. In these assays, one unit is defined as the ...reduce the cytopathic effect of viral infection by...
Mae II from Roche Applied Science
Biology Products:
(Date:11/24/2009)...upus Research Institute (LRI) today named 12 new g...6 million, recognize innovative work across a broa...r their creativity, novelty, and potential to driv...t, and cure the complex disease of systemic lupus....d lupus researchers across the nation and include ...
(Date:11/24/2009)...ger and the American College of Medical Toxicology... the publication of the Journal of Medical Toxico...inning in March 2010. It was previously published... Journal of Medical Toxicology , an international... the science and practice of medical toxicology. ...
(Date:11/24/2009)... release is available in Spanish . , The pr... levels of inflammatory substances in the blood, h... shown by a research project of the University of ...cientist at the School of Pharmacy. , The projec... in relation to the control of body weight and inf...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7New biofactories produce rare healing substances in the endangered Devils claw plant 54597 1New biofactories produce rare healing substances in the endangered Devils claw plant 54597 2New biofactories produce rare healing substances in the endangered Devils claw plant 54597 3Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2
...in a key brain protein known to underlie a form of...nting the normal growth and branching of neurons, ...alfunction of the protein made by mutant forms of ...ultimately leading to their death. The loss of dop...y of PD, and loss of connections among such neuron...
... simple stream of one-letter characters in the hum...de. In order to decipher this level of architectu...ental and algorithmic methods to detect copy numbe...duplications of DNA segments. These technologies-...were used to create the first comprehensive map of...
...g reasons behind the dramatic increase in testicul...ong 15-to-35-year-old Caucasian men, is the focus ...tute (NCI) grant to Yale Public Health researcher ... for unknown reasons and this study will provide i...netic and other risk factors,?said Zheng, professo...
Other Biology News:Parkinson's mutation stunts neurons 2New technology used to construct the first map of structural variation in the human genome 2
(Date:11/27/2009)... A mechanised blue dye tes...n to packaging quality assurance one step closer f...contact leak testing machine developed by Sepha...en installed in several local and global pharma-co... address quality assurance and productivity improv...
(Date:11/25/2009)..., , DURHAM, N.C., Nov. 25 /PRNewswire/...led the first energy-efficient, single-treatment w...om carbon nanotubes to Andhra Pradesh, Minister of...her leaders in Hyderabad, India today. Initial tes...IT) Kanpur, confirmed that the majority of the dri...
(Date:11/25/2009)... Ambassador to Speak at Eco...ronto, Canada (Vocus) November 25, 2009 -- Ambassa...Who: ,David Appia, French Ambassador for Internati...t in France Agency ,To view a biography of David A...Ambassador Appia is available to meet with press t...
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2